Anti-ADAM-22 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibodies targeting ADAM-22, a non-catalytic metalloprotease-disintegrin involved in neuronal adhesion and LGI1 receptor function.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Pan, Monkey, Dog
UniProt
Q9P0K1
Size
100ug
Cat. #
RP1ADAM22

In stock

SKU
RP-ADAM22

Options

As low as: $130.00

Target Overview

ADAM-22 (Disintegrin and metalloproteinase domain-containing protein 22; UniProt Q9P0K1) is a 906-amino acid member of the ADAM family that functions as a non-catalytic metalloprotease-like protein. Unlike many ADAM family members, ADAM-22 lacks proteolytic activity but retains its disintegrin and cysteine-rich domains, enabling it to serve as a cell surface receptor. It is primarily expressed in the central nervous system, where it localizes to the cell membrane and functions as a neuronal receptor for LGI1 (leucine-rich glioma-inactivated 1). ADAM-22 serves as a probable integrin ligand in the brain and participates in the regulation of cell adhesion, cell spreading, and inhibition of cell proliferation. Its interaction with LGI1 is critical for synaptic transmission and neuronal excitability, making it relevant to studies of epilepsy, autoimmune encephalitis, and autism spectrum disorder. The propeptide domain-targeted antibodies from Triple Point Biologics recognize human ADAM-22 with predicted cross-reactivity in mouse, primate, and canine tissues.

Background

ADAM-22 belongs to the ADAM (A Disintegrin And Metalloproteinase) family but is distinguished by its lack of catalytic activity. Despite the absence of proteolytic function, ADAM-22 plays important roles in synaptic organization and neuronal network stability through its binding to LGI1. This interaction forms a trans-synaptic complex with presynaptic ADAM23 and postsynaptic receptors, crucial for regulating voltage-gated potassium channels and maintaining proper synaptic transmission. Mutations or autoantibodies targeting the LGI1-ADAM22 complex have been implicated in autoimmune limbic encephalitis and familial epilepsy syndromes. Recent immunoprecipitation studies have identified ADAM22 as part of a protein complex with LGI1, ADAM23, and DLG4 in autoimmune encephalitis cases, confirming its role as a target antigen in neuroinflammatory conditions (Kudo et al., 2026). Beyond its neurological functions, ADAM-22 has emerged in cancer research as a regulator of metastatic behavior. Wei et al. (2026) demonstrated that cancer-associated fibroblast-derived exosomal circMPP6 drives ovarian cancer metastasis by regulating ADAM22 expression and activating TGF-β/Smad signaling pathways. This finding positions ADAM-22 as a potential biomarker and therapeutic target in tumor progression studies. Additionally, proteome-wide Mendelian randomization analyses have identified ADAM-22 as a candidate biomarker for schizophrenia, further expanding its relevance in psychiatric research. Studies correlating ADAM family proteins with neuroplasticity in autism spectrum disorder have also highlighted ADAM-22 among key metalloproteinase-disintegrins worthy of investigation in neurodevelopmental contexts.

References

  1. Kudo A et al (2026) Association between the peptide spectrum match values of LGI1, ADAM22, ADAM23 and DLG4 in the immunoprecipitation products of five autoimmune encephalitis cases with LGI1 antibody: A case series. Intern Med. PubMed · doi:10.2169/internalmedicine.6503-25
  2. Wei X et al (2026) CAF-derived exosomal circMPP6 drives ovarian cancer metastasis by coordinating nuclear and cytoplasmic regulation of ADAM22 to activate TGF-β/Smad signaling. Int J Biol Sci. PubMed · doi:10.7150/ijbs.126013
  3. Lin J et al (2026) Proteome-wide Mendelian randomization and colocalization analyses identify potential biomarkers for schizophrenia. Front Psychiatry. PubMed · doi:10.3389/fpsyt.2026.1724567
  4. Halepoto DM et al (2025) Correlation Between A Disintegrin and Metalloproteinase (ADAM) Family Proteins (8, 10, 17, 22) and Link with Neuroplasticity in Autism Spectrum Disorder. Curr Issues Mol Biol. PubMed · doi:10.3390/cimb47120980

Additional Specifications

Gene Symbol ADAM22
UniProt ID Q9P0K1
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 26-222.
Immunogen (Metalloproteinase domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 239-438.
Immunogen (Cytoplasmic domain 823-906 amino acid forms)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 758-906.
Immunogen (Cytoplasmic domain 906, 867, 859 amino acid forms)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 758-906.
Alternate Names ADAM22, ADAM 22, Disintegrin and metalloproteinase domain-containing protein 22, Metalloproteinase-disintegrin ADAM22-3, Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2, MDC2

Frequently Asked Questions

What molecular weight should I expect for ADAM-22 on a Western blot?

ADAM-22 migrates at approximately 100-110 kDa on reducing SDS-PAGE, which is slightly higher than its predicted molecular weight of 99 kDa (906 amino acids). This discrepancy is likely due to post-translational modifications, particularly N-glycosylation at multiple sites within the extracellular domain. As a membrane-bound protein with a single transmembrane domain, you may observe the mature glycosylated form as the dominant band in brain lysates. If you detect multiple bands, consider that ADAM-22 may undergo differential glycosylation depending on neuronal cell type and maturation state.

What is the recommended starting dilution for ADAM-22 Western blots?

Start at 1:1000 dilution for Western blot applications, which is validated for this antibody. Because ADAM-22 expression is restricted primarily to central nervous system tissue, signal intensity will depend heavily on your sample source. Brain tissue lysates typically yield robust signal at 1:1000, but cultured neuronal cells may require optimization between 1:500 and 1:2000 depending on confluence and differentiation state. Always include a protein loading control and consider titrating the antibody with your specific lysate preparation, as detergent choice and extraction conditions affect membrane protein yield.

Does this antibody work in mouse and rat brain samples?

The antibody is validated for human samples and shows potential cross-reactivity with mouse based on sequence homology analysis. Human and mouse ADAM-22 share approximately 90% sequence identity, suggesting the epitope is likely conserved. Rat ADAM-22 has similar homology and is also predicted to cross-react. However, these species have not been formally validated in our hands, so we recommend running positive control human samples in parallel during your initial experiments and confirming band specificity by molecular weight and tissue distribution. Pan (chimpanzee) is also predicted but not validated.

What are appropriate positive and negative controls for ADAM-22 expression?

Human brain tissue lysate, particularly from cortex or hippocampus, serves as a strong positive control given ADAM-22's predominant CNS expression. Cultured primary neurons or differentiated neuroblastoma cell lines (such as SH-SY5Y after retinoic acid treatment) also express detectable levels. For negative controls, use non-neuronal tissues such as liver, lung, or HEK293 cells, which express minimal to undetectable ADAM-22. If investigating LGI1-ADAM-22 interactions, consider epilepsy-associated brain regions where this receptor complex plays a documented role in synaptic transmission. Confirm absence of signal in your negative control to verify antibody specificity.

Can I use this antibody for immunofluorescence on neuronal cultures?

This antibody is produced by Triple Point Biologics, which validates antibodies for Western blot as standard practice. Given that ADAM-22 is a cell-surface protein with an extracellular domain, it is suitable for immunofluorescence on fixed neuronal cultures. For surface staining, fix cells with 4% paraformaldehyde without permeabilization; for total ADAM-22 including intracellular pools, include a permeabilization step with 0.1-0.3% Triton X-100. Start with a 1:100-1:200 dilution and optimize based on signal-to-background ratio. ADAM-22 typically shows punctate membrane staining at synaptic sites in mature neurons.

How should I prepare neuronal samples to preserve ADAM-22 for Western blot?

ADAM-22 is a membrane-bound protein requiring detergent-based extraction. Use RIPA buffer or a comparable lysis buffer containing 1% NP-40 or Triton X-100 to solubilize membrane fractions effectively. Include protease inhibitors and work on ice to prevent degradation. For brain tissue, mechanical homogenization followed by brief sonication improves yield. Avoid repeated freeze-thaw cycles, which compromise membrane protein integrity. If signal is weak, consider enriching for membrane fractions using differential centrifugation rather than whole-cell lysates. Load 20-40 µg total protein per lane as a starting point, adjusting based on ADAM-22 abundance in your specific sample type.

Are there known ADAM-22 isoforms I should be aware of?

ADAM-22 exists primarily as a single isoform (UniProt Q9P0K1, 906 amino acids), which is the canonical form expressed in the nervous system. Unlike some ADAM family members that undergo extensive alternative splicing, ADAM-22 does not have well-characterized functional splice variants reported in the literature. You should expect a single prominent band around 100-110 kDa under reducing conditions. If you observe multiple bands, this more likely reflects differential glycosylation states or proteolytic processing rather than distinct isoforms. The protein consists of a prodomain, metalloprotease-like domain (catalytically inactive), disintegrin, cysteine-rich, EGF-like, transmembrane, and cytoplasmic domains in its full-length form.

What are the storage and handling requirements for this antibody?

Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase background. The 100 µg pack size is supplied as a rabbit polyclonal and typically provided in a glycerol- or BSA-containing storage buffer that remains stable for at least 12 months when stored properly. Once thawed, an aliquot can be stored at 4°C for up to one month for convenient repeated use. Always centrifuge briefly before use to pellet any aggregates that may have formed during storage. Do not store diluted antibody in working solutions; prepare fresh dilutions in blocking buffer for each experiment to maintain optimal performance.

Western blot validation for RP-ADAM22 — 4 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

ADAM-22: Propeptide domain — WB validation
WB · Panel 1 ADAM-22: Propeptide domain
ADAM-22: Metalloproteinase domain — WB validation
WB · Panel 2 ADAM-22: Metalloproteinase domain
ADAM-22: Cytoplasmic domain 823-906 amino acid forms — WB validation
WB · Panel 3 ADAM-22: Cytoplasmic domain 823-906 amino acid forms
ADAM-22: Cytoplasmic domain 906, 867, 859 amino acid forms — WB validation
WB · Panel 4 ADAM-22: Cytoplasmic domain 906, 867, 859 amino acid forms

Custom validation studies available on request — contact us.

Also known as:

  • ADAM22
  • ADAM 22
  • Disintegrin and metalloproteinase domain-containing protein 22
  • Metalloproteinase-disintegrin ADAM22-3
  • Metalloproteinase-like
  • disintegrin-like
  • and cysteine-rich protein 2
  • MDC2
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →